AGNP BOARD EXAM
QUESTIONS Orthopedics
Prescribing (103 Questions)
GRADED A++
LATEST QUESTIONS AND
ANSWERS
,AGNP BOARD EXAM QUESTIONS Orthopedics Prescribing (103 Questions)
Question:
Which medication is NOT a brand name for acetaminophen?
Mapap
Cetafen
Aleve Correct
Feverall
Explanation:
Brand names for acetaminophen include Mapap, Cetafen, FeverAll and Tylenol. Aleve is the brand name for
naproxen sodium.
Question:
To treat low back pain in a patient for whom nonsteroidal anti-inflammatory drugs (NSAIDs) are
contraindicated, the recommended therapy is:
acetaminophen (Tylenol). Correct
ibuprofen (Motrin).
cyclobenzaprine (Amrix).
tramadol (Ultram).
Explanation:
To treat low back pain in a patient for whom nonsteroidal anti-inflammatory drugs (NSAIDs) are
contraindicated, the recommended therapy is acetaminophen (Tylenol). A nonsteroidal anti-inflammatory
drug (ibuprofen) is recommended as initial therapy for the treatment of back pain. The trial should be
short-term, usually 2 to 4 weeks. Acetaminophen is a reasonable option for initial therapy in patients with
contraindications to NSAIDs.
Question:
The patient at highest risk for side effects from cyclobenzaprine (Amrix) is a:
20-year-old man with spasticity and a history of seizures.
40-year-old woman diagnosed with diabetes mellitus.
50-year-old woman with a history of asthma.
70-year-old man diagnosed with benign prostatic hypertrophy. Correct
Explanation:
Cyclobenzaprine (Amrix) is identified in the Beers Criteria as a potentially inappropriate medication and
should be to be avoided in patients 65 years and older (independent of diagnosis or condition). This is
because most muscle relaxants are poorly tolerated in older adults due to anticholinergic effects. Amrix
may also increase sedation and fracture risk. Cyclobenzaprine (Amrix) has strong anticholinergic
properties. In addition, efficacy is questionable at doses tolerated by geriatric patients. Although
cyclobenzaprine may lower the seizure threshold, it is not a contraindication. The provider should weigh
the risks versus the benefits.
,Question:
When assessing a patient with suspected acetaminophen (Tylenol) overdose, the time of ingestion can be
confirmed by checking:
acetaminophen levels now and in 4 hours. Correct
baseline acetaminophen levels.
liver function studies now and in 4 hours.
acetylcysteine levels.
Explanation:
When assessing a patient with suspected acetaminophen (Tylenol) overdose, the time of ingestion can be
confirmed by checking serum acetaminophen levels at the time of presentation and again in 4 hours. This
is especially important if the time of acetaminophen ingestion is unknown.
Question:
A patient with severe osteoarthritis is complaining of a pain exacerbation due to weather change.
Ketorolac should be avoided in this patient due to a drug-drug interaction with:
diclofenac (Zorvolex). Correct
lisinopril (Zestril).
omega-3 fatty acids.
spironolactone (Aldactone).
Explanation:
The concomitant use of ketorolac (Toradol) and other nonsteroidal anti-inflammatory drugs (NSAIDs), such
as diclofenac (Zorvolex), is absolutely contraindicated due to enhancement of the adverse/toxic effect of
NSAIDs. Therapy should be monitored in the presence of ACE inhibitors, omega-3 fatty acids and
potassium-sparing diuretics, but it is not contraindicated.
Question:
The half-life elimination of colchicine (Colcrys), used in the treatment of gout, is approximately:
8 hours.
15 hours.
30 hours. Correct
48 hours.
Explanation:
The half-life elimination of colchicine (Colcrys) in an otherwise healthy person is about 27-31 hours.
Colchicine is an alkaloid indicated for the treatment of acute gout and for the prophylactic treatment of
gout. It is approved for use in patients aged 16 and older for gout prophylaxis.
Question:
Dantrolene (Dantrium) reduces skeletal muscle spasticity by:
interfering with the release of potassium from the sarcoplasmic reticulum.
interfering with the release of calcium from the sarcoplasmic reticulum. Correct
centrally blocking action potentials.
blocking the actin-myosin binding site in striated muscle.
, Explanation:
Dantrolene (Dantrium) reduces skeletal muscle spasticity by acting directly on skeletal muscle and
interfering with release of calcium ion from the sarcoplasmic reticulum. It is classified as a peripherally-
acting muscle relaxant. It is not a centrally-acting muscle relaxant.
Question:
Which formulation of naproxen would result in fewer GI side effects?
Naprosyn
Naprosyn suspension
Anaprox DS
EC-Naprosyn Correct
Explanation:
EC-Naprosyn dissolves in the small intestine rather than in the stomach. Fewer GI side effects would be
expected with this medication. However, this results in delayed absorption and thus delayed relief of acute
pain could also be anticipated. The other listed forms of naproxen are absorbed in the stomach and
produce a greater risk of GI upset.
Question:
Salicylates, such as aspirin,:
prevent the formation of clots by affecting blood coagulation.
inhibit vitamin K epoxide reductase and prevent blood clots.
inhibit the synthesis of prostaglandin in the process of inflammation. Correct
block the activity of clotting factor X and prevent blood clots.
Explanation:
Salicylates are nonsteroidal anti-inflammatory drugs (i.e. aspirin [Ecotrin] and magnesium salicylate
[Doan's]). Salicylates inhibit the synthesis of prostaglandins and other mediators in the process of
inflammation and have anti-inflammatory, antipyretic and analgesic properties.
Question:
When evaluating the effectiveness of baclofen (Lioresal), the LEAST appropriate goal is to:
reduce caregiver challenges such as dressing, feeding, transport, and bathing.
reduce the pain and frequency of muscle contractions.
improve voluntary motor functions such as reaching, releasing and grasping.
significantly reduce muscle spasticity and contractions. Correct
Explanation:
“Reducing spasticity” per se is not an appropriate treatment goal. Appropriate goals include increasing
range of motion, easing care, decreasing pain, improving quality of life, improving gait, or decreasing the
development of contractures. Use with caution when spasticity is utilized to sustain upright posture and
balance in locomotion, or when spasticity is necessary to obtain increased function.
Question:
The concomitant use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) can cause:
QUESTIONS Orthopedics
Prescribing (103 Questions)
GRADED A++
LATEST QUESTIONS AND
ANSWERS
,AGNP BOARD EXAM QUESTIONS Orthopedics Prescribing (103 Questions)
Question:
Which medication is NOT a brand name for acetaminophen?
Mapap
Cetafen
Aleve Correct
Feverall
Explanation:
Brand names for acetaminophen include Mapap, Cetafen, FeverAll and Tylenol. Aleve is the brand name for
naproxen sodium.
Question:
To treat low back pain in a patient for whom nonsteroidal anti-inflammatory drugs (NSAIDs) are
contraindicated, the recommended therapy is:
acetaminophen (Tylenol). Correct
ibuprofen (Motrin).
cyclobenzaprine (Amrix).
tramadol (Ultram).
Explanation:
To treat low back pain in a patient for whom nonsteroidal anti-inflammatory drugs (NSAIDs) are
contraindicated, the recommended therapy is acetaminophen (Tylenol). A nonsteroidal anti-inflammatory
drug (ibuprofen) is recommended as initial therapy for the treatment of back pain. The trial should be
short-term, usually 2 to 4 weeks. Acetaminophen is a reasonable option for initial therapy in patients with
contraindications to NSAIDs.
Question:
The patient at highest risk for side effects from cyclobenzaprine (Amrix) is a:
20-year-old man with spasticity and a history of seizures.
40-year-old woman diagnosed with diabetes mellitus.
50-year-old woman with a history of asthma.
70-year-old man diagnosed with benign prostatic hypertrophy. Correct
Explanation:
Cyclobenzaprine (Amrix) is identified in the Beers Criteria as a potentially inappropriate medication and
should be to be avoided in patients 65 years and older (independent of diagnosis or condition). This is
because most muscle relaxants are poorly tolerated in older adults due to anticholinergic effects. Amrix
may also increase sedation and fracture risk. Cyclobenzaprine (Amrix) has strong anticholinergic
properties. In addition, efficacy is questionable at doses tolerated by geriatric patients. Although
cyclobenzaprine may lower the seizure threshold, it is not a contraindication. The provider should weigh
the risks versus the benefits.
,Question:
When assessing a patient with suspected acetaminophen (Tylenol) overdose, the time of ingestion can be
confirmed by checking:
acetaminophen levels now and in 4 hours. Correct
baseline acetaminophen levels.
liver function studies now and in 4 hours.
acetylcysteine levels.
Explanation:
When assessing a patient with suspected acetaminophen (Tylenol) overdose, the time of ingestion can be
confirmed by checking serum acetaminophen levels at the time of presentation and again in 4 hours. This
is especially important if the time of acetaminophen ingestion is unknown.
Question:
A patient with severe osteoarthritis is complaining of a pain exacerbation due to weather change.
Ketorolac should be avoided in this patient due to a drug-drug interaction with:
diclofenac (Zorvolex). Correct
lisinopril (Zestril).
omega-3 fatty acids.
spironolactone (Aldactone).
Explanation:
The concomitant use of ketorolac (Toradol) and other nonsteroidal anti-inflammatory drugs (NSAIDs), such
as diclofenac (Zorvolex), is absolutely contraindicated due to enhancement of the adverse/toxic effect of
NSAIDs. Therapy should be monitored in the presence of ACE inhibitors, omega-3 fatty acids and
potassium-sparing diuretics, but it is not contraindicated.
Question:
The half-life elimination of colchicine (Colcrys), used in the treatment of gout, is approximately:
8 hours.
15 hours.
30 hours. Correct
48 hours.
Explanation:
The half-life elimination of colchicine (Colcrys) in an otherwise healthy person is about 27-31 hours.
Colchicine is an alkaloid indicated for the treatment of acute gout and for the prophylactic treatment of
gout. It is approved for use in patients aged 16 and older for gout prophylaxis.
Question:
Dantrolene (Dantrium) reduces skeletal muscle spasticity by:
interfering with the release of potassium from the sarcoplasmic reticulum.
interfering with the release of calcium from the sarcoplasmic reticulum. Correct
centrally blocking action potentials.
blocking the actin-myosin binding site in striated muscle.
, Explanation:
Dantrolene (Dantrium) reduces skeletal muscle spasticity by acting directly on skeletal muscle and
interfering with release of calcium ion from the sarcoplasmic reticulum. It is classified as a peripherally-
acting muscle relaxant. It is not a centrally-acting muscle relaxant.
Question:
Which formulation of naproxen would result in fewer GI side effects?
Naprosyn
Naprosyn suspension
Anaprox DS
EC-Naprosyn Correct
Explanation:
EC-Naprosyn dissolves in the small intestine rather than in the stomach. Fewer GI side effects would be
expected with this medication. However, this results in delayed absorption and thus delayed relief of acute
pain could also be anticipated. The other listed forms of naproxen are absorbed in the stomach and
produce a greater risk of GI upset.
Question:
Salicylates, such as aspirin,:
prevent the formation of clots by affecting blood coagulation.
inhibit vitamin K epoxide reductase and prevent blood clots.
inhibit the synthesis of prostaglandin in the process of inflammation. Correct
block the activity of clotting factor X and prevent blood clots.
Explanation:
Salicylates are nonsteroidal anti-inflammatory drugs (i.e. aspirin [Ecotrin] and magnesium salicylate
[Doan's]). Salicylates inhibit the synthesis of prostaglandins and other mediators in the process of
inflammation and have anti-inflammatory, antipyretic and analgesic properties.
Question:
When evaluating the effectiveness of baclofen (Lioresal), the LEAST appropriate goal is to:
reduce caregiver challenges such as dressing, feeding, transport, and bathing.
reduce the pain and frequency of muscle contractions.
improve voluntary motor functions such as reaching, releasing and grasping.
significantly reduce muscle spasticity and contractions. Correct
Explanation:
“Reducing spasticity” per se is not an appropriate treatment goal. Appropriate goals include increasing
range of motion, easing care, decreasing pain, improving quality of life, improving gait, or decreasing the
development of contractures. Use with caution when spasticity is utilized to sustain upright posture and
balance in locomotion, or when spasticity is necessary to obtain increased function.
Question:
The concomitant use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) can cause:
